Net gamma exposure for Beam Therapeutics Inc (BEAM) options was positive at the Nov 4, 2026 close, about $350.39K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for BEAM, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for BEAM, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for BEAM, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
BEAM Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is BEAM gamma exposure positive or negative?
Beam Therapeutics net gamma exposure was positive on Nov 4, 2026, at $350.39K. It has been positive on 20 of the last 20 trading days.
How has BEAM gamma exposure changed recently?
Beam Therapeutics net gamma exposure went from $147.09K on Oct 7, 2026 to $350.39K on Nov 4, 2026. See the BEAM gamma exposure history for a longer view.
What is Beam Therapeutics Inc?
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases.